| [1] Tsai HC，Baylin SB. Cancer epigenetics：linking basic biology to clinical medicine[J]. Cell Res，2011，21 (3)：502-517. [2] Hundt S，Haug U，Brenner H. Blood markers for early detection of colorectal cancer：a systematic review[J]. Cancer Epidemiol Biomarkers Prev，2007，16 (10)：1935-1953. [3] Kulasingam V，Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies [J]. Nat Clin Pract Oncol，2008，5(10)：588-599. [4] Glinka A，Wu W，Delius H，et al. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction[J]. Nature，1998，391(6665)：357-362. [5] Peifer M，Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus[J]. Science， 2000，287(5458)：1606-1609. [6] Yang Y. Wnts and wing：Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis[J]. Birth Defects Res C Embryo Today，2003，69(4)：305-317. [7] Sem?nov MV，Tamai K，Brott BK，et al. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6[J]. Curr Biol，2001，11(12)：951-961. [8] Mao B，Wu W，Davidson G，et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling[J]. Nature，2002，417(6889)：664-667. [9] Menezes ME，Devine DJ，Shevde LA，et al. Dickkopf1：a tumor suppressor or metastasis promoter?[J]. Int J Cancer， 2012，130(7)：1477-1483. [10] Forget MA，Turcotte S，Beauseigle D，et al. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types[J]. Br J Cancer，2007，96(4)：646-653. [11] Hirata H，Hinoda Y，Nakajima K，et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma[J]. Int J Cancer， 2011，128(8)：1793-1803. [12] Mitra A，Menezes ME，Shevde LA，et al. DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype[J]. J Biol Chem，2010， 285(32)： 24686-24694. [13] El-Serag HB，Marrero JA，Rudolph L，et al. Diagnosis and treatment of hepatocellular carcinoma[J]. Gastroenterology， 2008，134(6)：1752-1763. [14] Sato N，Yamabuki T，Takano A，et al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy[J]. Cancer Res， 2010，70(13)：5326-5336. [15] Tung EK，Mak CK，Fatima S，et al. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma[J]. Liver Int，2011，31(10)： 1494-1504. [16] Shen Q，Fan J，Yang XR，et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma：a large-scale，multicentre study[J]. Lancet Oncol，2012， 13(8)：817-826. [17] Yamabuki T，Takano A，Hayama S，et al. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas[J]. Cancer Res，2007，67(6)：2517-2525. [18] Sheng SL，Huang G，Yu B，et al. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer[J]. Clin Chem，2009，55(9)：1656-1664. [19] Lee HS，Lee HE，Park do J，et al. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer[J]. Clin Chim Acta，2012，413(21/22)：1753-1760. [20] Gomceli I，Bostanci EB，Ozer I，et al. A novel screening biomarker in gastric cancer：serum Dickkopf-1[J]. Hepato-gastroenterology， 2012，59(117)：1661-1664. [21] Voorzanger-Rousselot N，Goehrig D，Journe F，et al. Increased Dickkopf-1 expression in breast cancer bone metastases [J]. Br J Cancer， 2007，97(7)：964-970. [22] Voorzanger-Rousselot N，Journe F，Doriath V，et al. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases[J]. Calcif Tissue Int， 2009，84(5)：348-354. [23] Feldmann R，Schierl M，Fink AM，et al. Serum levels of glycoprotein Dickkopf-1 in patients with cutaneous malignant melanoma：a prospective pilot study[J]. Dermatology， 2011， 222(2)：171-175. [24] Kaiser M，Mieth M，Liebisch P，et al. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma[J]. Eur J Haematol， 2008， 80(6)： 490-494. [25] Politou MC，Heath DJ，Rahemtulla A，et al. Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation [J]. Int J Cancer， 2006，119(7)：1728-1731. [26] Jiang T，Wang S，Huang L，et al. Clinical significance of serum DKK-1 in patients with gynecological cancer[J]. Int J Gynecol Cancer， 2009，19(7)：1177-1181. [27] Lee N，Smolarz AJ，Olson S，et al. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies[J]. Br J Cancer， 2007，97(11)：1552-1559. [28] Roato I，D'Amelio P，Gorassini E，et al. Osteoclasts are active in bone forming metastases of prostate cancer patients[J]. PLoS One， 2008，3(11)：3627. [29] 郭长城，罗 俊，杨丰强，等. 膀胱癌患者血清DKK-1和DKK-3 表达及其临床意义[J]. 肿瘤，2013，33(1)：81-84. |
